IL97758A0 - Epithelins:cysteine-rich growth modulating proteins - Google Patents

Epithelins:cysteine-rich growth modulating proteins

Info

Publication number
IL97758A0
IL97758A0 IL97758A IL9775891A IL97758A0 IL 97758 A0 IL97758 A0 IL 97758A0 IL 97758 A IL97758 A IL 97758A IL 9775891 A IL9775891 A IL 9775891A IL 97758 A0 IL97758 A0 IL 97758A0
Authority
IL
Israel
Prior art keywords
epithelin
growth
epithelins
purified
precursor
Prior art date
Application number
IL97758A
Other languages
English (en)
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of IL97758A0 publication Critical patent/IL97758A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL97758A 1990-04-03 1991-04-03 Epithelins:cysteine-rich growth modulating proteins IL97758A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50450890A 1990-04-03 1990-04-03
US07/668,648 US5416192A (en) 1990-04-03 1991-03-13 Epithelins: novel cysteine-rich growth modulating proteins

Publications (1)

Publication Number Publication Date
IL97758A0 true IL97758A0 (en) 1992-06-21

Family

ID=27054846

Family Applications (1)

Application Number Title Priority Date Filing Date
IL97758A IL97758A0 (en) 1990-04-03 1991-04-03 Epithelins:cysteine-rich growth modulating proteins

Country Status (15)

Country Link
US (3) US5416192A (hu)
EP (1) EP0527806B1 (hu)
CN (1) CN1058782A (hu)
AT (1) ATE162549T1 (hu)
AU (1) AU639787B2 (hu)
CA (1) CA2079218A1 (hu)
CS (1) CS91791A3 (hu)
DE (1) DE69128779D1 (hu)
GR (1) GR3026263T3 (hu)
HU (1) HUT63438A (hu)
IE (1) IE911117A1 (hu)
IL (1) IL97758A0 (hu)
NZ (1) NZ237661A (hu)
OA (1) OA09711A (hu)
WO (1) WO1991015510A1 (hu)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993015195A1 (en) * 1992-02-03 1993-08-05 Samuel Solomon Granulins from leukocytes
WO2000075316A1 (en) * 1999-06-02 2000-12-14 Genentech, Inc. Methods and compositions for inhibiting neoplastic cell growth
WO2001049715A2 (en) * 2000-01-06 2001-07-12 Genentech, Inc. Methods and compositions for inhibiting neoplastic cell growth
WO2000032778A2 (en) * 1998-12-01 2000-06-08 Genentech, Inc. Methods and compositions for inhibiting neoplastic cell growth
WO2000053751A1 (en) * 1999-03-08 2000-09-14 Genentech, Inc. Methods and compositions for inhibiting neoplastic cell growth
US20100111928A1 (en) * 1997-05-23 2010-05-06 A & G Pharmaceutical, Inc. Methods and kits for diagnosis tumorgenicity
US6309826B1 (en) * 1997-05-23 2001-10-30 Ginette Serrero 88kDa tumorigenic growth factor and antagonists
US8512960B2 (en) * 1997-05-23 2013-08-20 A&G Pharmaceutical, Inc. 88kDa tumorigenic growth factor and antagonists
US6881548B2 (en) 1997-05-23 2005-04-19 A&G Pharmaceutical, Inc. Methods and kits for diagnosing tumorigenicity and determining resistance to the antineoplastic effects of antiestrogen therapy
US7091047B2 (en) 1997-05-23 2006-08-15 A&G Pharmaceutical, Inc. Methods and kits for diagnosing tumorigenicity
US20030215445A1 (en) * 1997-05-23 2003-11-20 Ginette Serrero Methods and compositions for inhibiting the growth of hematopoietic malignant cells
US6720159B1 (en) * 1997-12-16 2004-04-13 A&G Pharmaceutical, Inc. 88KDA tumorigenic growth factor and antagonists
DK1121439T3 (da) * 1998-10-13 2006-11-13 Genentech Inc Fremgangsmåder og præparater til inhibering af neoplastisk cellevækst
EP1820859B9 (en) * 1998-12-22 2009-10-28 Genentech, Inc. Methods and compositions for inhibiting neoplastic cell growth
MXPA01006330A (es) * 1998-12-22 2002-07-02 Genentech Inc Metodos y composiciones para inhibir el crecimiento de celulas neoplasticas.
AU1749800A (en) * 1999-03-12 2000-10-04 Genentech Inc. Methods and compositions for inhibiting neoplastic cell growth
AU3246100A (en) * 1999-06-02 2000-12-28 Genentech Inc. Methods and compositions for inhibiting neoplastic cell growth
DK1185648T3 (da) * 1999-06-02 2007-07-30 Genentech Inc Fremgangsmåder og sammensætninger til inhibition af neoplastisk cellevækst
EP1873244A3 (en) * 1999-06-02 2008-04-02 Genentech, Inc. Methods and compositions for inhibiting neoplastic cell growth
AU2001241877A1 (en) * 2000-02-28 2001-09-12 The Regents Of The University Of California Methods for detection and treatment of neural cancers
US6872703B2 (en) 2000-06-07 2005-03-29 Ajinomoto Co., Inc. Insulin receptor-related receptor binding protein
AUPR673001A0 (en) * 2001-07-31 2001-08-23 Prince Henry's Institute Of Medical Research Pregnancy-related enzyme activity
WO2003074674A2 (en) * 2002-03-01 2003-09-12 Exelixis, Inc. MSRAs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
US7411045B2 (en) 2002-11-19 2008-08-12 A&G Pharmaceutical, Inc. Autocrine growth factor receptor antibodies and methods
EP1601687B1 (en) * 2003-02-26 2010-10-06 A & G Pharmaceuticals, Inc. Methods for increasing the proliferation of b cells
EP1644038A2 (en) * 2003-06-23 2006-04-12 A & G Pharmaceuticals, Inc. Compositions and methods for restoring sensitivity of tumor cells to antitumor therapy and inducing apoptosis
WO2005009217A2 (en) * 2003-07-21 2005-02-03 Medimmune, Inc. Diagnosis of pre-cancerous conditions using pcdgf agents
EP1660010B1 (en) * 2003-08-01 2013-07-24 A & G Pharmaceutical, Inc. Compositions and methods for restoring sensitivity to treatment with her2 antagonists
EP2331711B1 (en) 2008-09-05 2017-02-22 A & G Pharmaceutical, Inc. Methods for diagnosing cancer and determining the overall survival and disease-free survival of cancer patients
US8362218B2 (en) 2009-04-17 2013-01-29 New York University School Of Medicine Peptides targeting TNF family receptors and antagonizing TNF action, compositions, methods and uses thereof
US9913399B2 (en) 2015-02-09 2018-03-06 Dell Products, Lp System and method for wireless rack management controller communication

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4590003A (en) * 1984-03-23 1986-05-20 Oncogen Platelet related growth regulator

Also Published As

Publication number Publication date
HU9203137D0 (en) 1992-12-28
DE69128779D1 (de) 1998-02-26
WO1991015510A1 (en) 1991-10-17
CA2079218A1 (en) 1991-10-04
AU639787B2 (en) 1993-08-05
US5885961A (en) 1999-03-23
NZ237661A (en) 1993-07-27
HUT63438A (en) 1993-08-30
GR3026263T3 (en) 1998-05-29
OA09711A (en) 1993-08-30
AU7744791A (en) 1991-10-30
US5965723A (en) 1999-10-12
US5416192A (en) 1995-05-16
EP0527806B1 (en) 1998-01-21
EP0527806A4 (en) 1993-05-05
ATE162549T1 (de) 1998-02-15
EP0527806A1 (en) 1993-02-24
CS91791A3 (en) 1992-06-17
IE911117A1 (en) 1991-10-09
CN1058782A (zh) 1992-02-19

Similar Documents

Publication Publication Date Title
IL97758A0 (en) Epithelins:cysteine-rich growth modulating proteins
ATE194658T1 (de) Das dorsalgewebe beeinflussender faktor
HK1007335A1 (en) Production of insulin-like growth factor binding protein
ATE149524T1 (de) Dns, die ein menschliches, gefässverengendes peptid kodiert, und dessen verwendung
DE3785864T2 (de) Verfahren zur Herstellung von menschlichem Epidermalwachstumsfaktor und dessen Analogen.
MX9602259A (es) Proteina modificada quimicamente en el nitrogeno terminal, composiciones que las incluyen y metodos para su preparacion.
CA2223433A1 (en) Ob protein compositions and methods
AU8007087A (en) New forms of colony stimulating factor-1
EP0759067A4 (en) TRANSFORMING GROWTH FACTOR ALPHA H1
CA2019363A1 (en) Dna and use thereof
EP0218531A3 (en) Immunogenic peptides of human interleukin-1 and the corresponding anti-peptide antibodies
GR3031927T3 (en) Cysteine depleted il-6 muteins
HU895788D0 (en) Process for producing peptides and medical products containing them
DE69004794T2 (de) Verwendung eines Polypeptids mit Interleukin 2-Aktivität zur Herstellung einer zur Behandlung von einfachen Pleurageschwüren bestimmten pharmazeutischen Zusammensetzung.
EP0315118A3 (en) Dna coding for endothelin and use thereof
EP0516845A4 (en) NEW MEGAKARYOCYTIC COLONY-STIMULATING FACTOR AND METHOD FOR THE PRODUCTION THEREOF.
Shoyah et al. Epitheli
NO923861L (no) Epiteliner: nye vekstregulerende proteiner
Kells The effects of transforming growth factor-beta on the growth of osteoblast-enriched cultures derived from adult human bone.
MX9800686A (es) Nueva proteina hmw humana mp52s.
NZ337632A (en) Method for inhibiting human vascular IBF-like growth factor (VIGF) comprising a VIGF polypeptide or polypeptide having the cDNA contained in ATCC 75874
MD218C2 (ro) Stimulant pentru creşterea părului
ES2005114A6 (es) Procedimiento de producir factor de crecimiento de celulas endoteliales humano